[Skip to Navigation]
Comment & Response
April 13, 2022

Image Consent and the Development of Image-Based Artificial Intelligence—Reply

Roxana Daneshjou, MD, PhD1,2; Veronica Rotemberg, MD, PhD3; for the International Skin Imaging Collaboration Artificial Intelligence Working Group
Author Affiliations
  • 1Department of Dermatology, Stanford School of Medicine, Redwood City, California
  • 2Department of Biomedical Data Science, Stanford School of Medicine, Stanford, California
  • 3Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York
JAMA Dermatol. 2022;158(5):590. doi:10.1001/jamadermatol.2022.0108

In Reply We read with interest the response of Kovarik et al to our consensus statement.1 The scope of our effort in developing the Checklist for Evaluation of Image-Based Artificial Intelligence Reports in Dermatology consensus guidelines was restricted to technical aspects of the development and reporting of image-based artificial intelligence (AI) in dermatology. We agree that questions associated with patient consent are crucial, but our assessment is that further research and broader participation are required to develop formal consent guidelines. Such efforts should consider existing regulatory and legal requirements, which vary geographically, as well as ethical issues. We would point out that the General Data Protection Regulation of Europe, which is among the more stringent legal frameworks that establish guidelines for collecting and processing personal information, allows sharing of deidentified data for AI use.2,3 We believe that formal research on patient preferences and potential harms is needed to inform the answers to the questions of Kovarik et al. We, among others, are actively engaged in conducting such research, and we strongly endorse the development of guidelines around patient consent for images used in AI.

Add or change institution